Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging

NMR in Biomedicine

Volumn 9, Issue 4, 1996, Pages 141-155

  Li, C W ^a   Negendank, W G ^a   Murphy Boesch, J ^a   Padavic Shaller, K ^a   Brown, T R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID; PHOSPHORUS;

ADULT; ARTICLE; FEMALE; HUMAN; IMAGE PROCESSING; INDIVIDUALITY; LIVER; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY;

ADULT; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDIVIDUALITY; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PHOSPHORUS; REPRODUCIBILITY OF RESULTS;

EID: 0030159425     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199606)9:4<141::AID-NBM403>3.0.CO;2-P     Document Type: Article

References (64)

1. 31P magnetic resonance spectroscopy. Lancet 1, 931-934 (1987).
2. Cox, I. J., Bryant, D. J., George, P., Harman, R. R., Hall, A. S., Hodgson, H. J. F, Khenia, S., McArthur, P. and Spencer, D. H. Four-dimensional chemical shift MR imaging of phosphorus metabolites of normal and diseased human liver. J. Comput. Assist. Tomog. 12, 369-376 (1988).
3. Meyerhoff, D, J., Boska, M. D., Thomas, A. M. and Weiner, M. W. Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy. Radiology 173, 393-400 (1989).
4. Oberhaensli, R., Rajagopalan, B., Galloway, G. J., Taylor, D. J. and Radda, G. K. Study of human liver disease with P-31 magnetic resonance spectroscopy. Gut 31, 463-467 (1990).
5. Angus, P. W., Dixon, R. M., Rajagopalan, B. and Radda, G. K. A study of patients with alcoholic liver disease by P-31 nuclear magnetic resonance spectroscopy. Clin. Sci. 78, 33 (1990).
6. Sakuma, H., Itabashi, K., Takeda, K., Hirano, T., Kinosada, Y., Nakagawa, T., Yamada, M. and Nakano, T. Serial P-31 MR spectroscopy after frucstose infusion in patients with chronic hepatitis. J. Magn. Reson. Imag. 1, 701-704 (1991).
7. Cox, I. J., Menon, D. K., Sargentoni, J., Bryant, D. J., Collins, A. G., Coutts, G. A., lles, R. A., Bell, J. D., Benjamin, I. S., Gilbey, S., Hodgson, H. J. F. and Morgan, M. Y. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J. Hepat. 14, 265-275 (1992).
8. Rajanayagam, V., Lee, R. R., Ackerman, Z., Bradley, W. G. and Ross, B. D. Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis. J. Magn. Reson. Imag. 2, 183-190 (1992).
9. 31P MR spectroscopy from patients with focal and diffuse liver disease. Magn. Reson. Imag. 10, 949-956 (1992).
10. 31P spectroscopy. Hepatology 15, 835-842 (1992).
11. 31P magnetic resonance spectroscopy. Pediat. Res. 32, 39-44 (1992).
12. 31P magnetic resonance spectroscopy detects a functional abnormality in liver metabolism after acetaminophen poisoning. Hepatology 16, 943-948 (1992).
13. 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed. 6, 168-172 (1993).
14. Yamane, Y., Umeda, M., O'uchi, T., Mitsuhima, T., Nakata, K. and Nagataki, S. Phosphorus-31 nuclear magnetic resonance in vivo spectroscopy of human liver during hepatitis A virus infection. Digest. Dis. Sci. 39, 33-38 (1994).
15. 31P magnetic resonance spectroscopy. Pediat. Res. 36, 436-440 (1994).
16. Menon, D. K., Sargentoni, J., Taylor-Robinson, S. D., Bell, J. D., Cox, J., Bryant, D. J., Coutts, G. A., Rolles, K., Burroughs, A. K. and Morgan, M. Y. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 21, 417-427 (1995).
17. 31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical and histological changes in diffuse liver disease. Hepatology 21, 443-449 (1995).
18. 31P Nuclear magnetic resonance spectroscopy investigation of human neuroblastoma in situ. New Engl. J. Med. 6, 1500-1505 (1985).
19. Glazer, G. M., Smith, S. R., Chenevert, T. L., Martin, P. A., Stevens, A. N. and Edwards, R. H. T. Image localized P-31 magnetic resonance spectroscopy of the human liver. NMR Biomed. 1, 184-189 (1989).
20. 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Brit J. Cancer 63, 953-958 (1991).
21. Francis, I. R., Chenevert, T. L, Gubin, B., Collomb, L., Ensminger, W., Walker-Andrews, S. and Glazer, G. M. Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging. Radiology 180, 341-344 (1991).
22. 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed. 5, 114-120 (1992).
23. Meyerhoff, D. J., Karczmar, G. S., Valone, R, Venook, A., Matson, G. B. and Weiner, M. W. Hepatic cancers and their response to chemoembolization therapy. Invest. Radiol. 27, 456-464 (1992).
24. Schilling, A., Gewiese, B., Berger, G. and Wolf, K. J. Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization. Radiology 182, 887-890 (1992).
25. 31P NMR spectroscopy. NMR Biomed. 1, 177-183 (1989).
26. 1H decoupling schemes. Proc. Soc. Magn. Reson. 3, 3312 (1992).
27. 1H} double-resonance experiments in a 1.5 T whole-body MR system. Magn. Reson. Med. 15, 165-172 (1990).
28. Bottomley, P. A. and Hardy, C. J. Proton Overhauser enhancements in human cardiac phosphorus NMR spectroscopy at 1.5 T. Magn. Reson. Med. 24, 384-390 (1992).
29. 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed. 6, 173-180 (1993).
30. Negendank, W. G., Padavic-Shaoller, K. A., Li, C. W., Murphy-Boesch, J., Stoyanova, R., Krigel, R. L., Schilder, R. J., Smith, M. R. and Brown, T. R. Metabolic characterization of human non-Hodgkin's lymphomas in vivo using proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 55, 3286-3294 (1995).
31. 31P signal. Magn. Reson. Med. 12, 145-150 (1989).
32. 31P-NMR spectra at low magnetic field strengths. Biochim. Biophys. Acta. 1111, 51-58 (1992).
33. 31P NMR spectra in vivo. Magn. Reson. Med. 12, 282-289 (1989).
34. 31P NMR spectra of the human brain in vivo. NMR Biomed. 7, 237-242 (1994).
35. 31P magnetic resonance spectroscopy. NMR Biomed. 3, 17-22 (1990).
36. 31P MRS in vivo. Part II: muscle, kidney. Magn. Reson. Med. 32, 453-458 (1994).
37. 31P spectroscopy. NMR Biomed. 2, 284-289 (1989).
38. Brown, T. R. Practical applications of chemical shift imaging. NMR Biomed. 5, 238-243 (1992).
39. Brown, T. R., Kincaid, B. M. and Ugurbil, K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA 79, 3523-3526 (1982).
40. 31P-MR spectrum of the healthy liver. Fortschr. Rontgenstr. 153, 369-372 (1990).
41. Liu, Z., Javaid, T., Hu, J. and Brown, T. R. CSI-autoshim procedure for body and surface coil. Proc. Soc. Magn. Reson. 3, 1174 (1994).
42. 1H chemical shift imaging. J. Magn. Reson. B. 108, 213-219 (1995).
43. Staewen, R. S., Johnson, A. J., Ross, B. D., Parrish, T., Merkle, H. and Garwood, M. Three-dimensional FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Invest. Radiol. 25, 559-567 (1990).
44. Bottomley, P. A. and Ouwerkerk, R. BIRP, an improved implementation of low-angle adiabatic (BIR-4) excitation pulses. J. Magn. Reson. 103, 242-244 (1993).
45. Christensen, K. A., Grant, D. M., Schulman, E. M. and Walling, C. Optimal determination of relaxation times of Fourier transform nuclear magnetic resonance. Determination of spin-lattice relaxation times in chemically polarized species. J. Phys. Chem. 78, 1971-1978 (1974).
46. Gupta, R. K. A new look at the method of variable nutation angle for the measurement of spin-lattice relaxation times using Fourier transform NMR. J. Magn. Reson. 25, 231-235 (1977).
47. Vigneron, D. B., Nelson, S. J., Murphy-Boesch, J., Kelley, D. A. C., Kessler, H. B., Brown, T. R. and Taylor, J. S. Chemical shift imaging of human brain: axial, sagittal, and coronal P-31 metabolite image. Radiology 177, 643-649 (1990).
48. 31P magnetic resonance. J. Biol. Chem. 248, 7276-7278 (1973).
49. Murphy-Boesch, J., Jiang, H., Stoyanova, R. and Brown, T. R. Quantitation of phosphorus metabolites from CSI spectra with corrections for point spread effects and B, inhomogeneity. Magn. Reson. Med. (1995) (submitted).
50. Ramo, S., Whinnery, J. R. and Van Duzer, T. Fields and waves in communication electronics. Wiley, New York (1965).
51. 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim. Biophys. Acta. 1225, 71-77 (1993).
52. Petersen, A., Kappler, F., Szwergold, B. S. and Brown, T. R. Fructose metabolism in the human erythrocyte. Biochem. J. 284, 363-366 (1992).
53. Lautt, W. W. Hepatic vasculature: a conceptual review. Gastroenterology 73, 1163-1169 (1977).
54. Cohen, S. M. Application of nuclear magnetic resonance to the study of liver physiology and disease. Hepatology 3, 738-749 (1983).
55. 31P magnetic resonance spectra of normal human liver: toward biochemical pathology in vivo. Clin. Soi. 83, 183-190 (1992).
56. 1 relaxation times of phosphorylated metabolites in human calf muscle at 1.5 Tesla. Magn. Reson. Med. 33, 417-421 (1995).
57. Hart, P. A. Phosphorus relaxation methods: conformation and dynamics of nucleic acids and proteins. In Phosphorus-31 NMR, ed. by D. G. Gorenstein, pp. 317-347. Academic Press, San Diego, CA.
58. 31P metabolites in model solutions at two frequencies: implications for in vivo spectroscopy. Magn. Reson. Imag. 8, 691-698 (1990).
59. Hultman, E., Nilsson, L H. and Sahiin, K. Adenine nucleotide content of human liver. Normal values and fructose-induced depletion. Scand. J. Clin. Lab. Invest. 35, 245-251 (1975).
60. 1 values of phosphorus metabolites in human liver and muscle determined at 1.5 T by chemical shift imaging. NMR Biomed. 2, 298-304 (1989).
61. 1 measurement in vivo with low-angle adiabatic pulses. J. Magn. Reson. 6104, 159-167 (1994).
62. van Ormondt, D., de Beer, R., Marien, A. J. H., den Hollander, J. A., Luyten, P. R. and Vermeulen, J. W. A. H. Two-dimensional approach to quantitation of inversion-recovery data. J. Magn. Reson. 88, 652-659 (1990).
63. Cox, I. J., Coutts, G. A., Gadian, D. G., Ghosh, P., Sargentoni, J. and Young, I. R. Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver. Magn. Reson. Med. 17, 53-61 (1991).
64. Kolem, H., Schneider, M., Wicklow, K. and Sauter, R. Fast In vivo phosphorus spectroscopy using nuclear Overhauser enhancement. Proc. Soc. Magn. Reson. 2, 889 (1990).